Your browser doesn't support javascript.
loading
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
Stewart, Mark; Rodriguez-Watson, Carla; Albayrak, Adem; Asubonteng, Julius; Belli, Andrew; Brown, Thomas; Cho, Kelly; Das, Ritankar; Eldridge, Elizabeth; Gatto, Nicolle; Gelman, Alice; Gerlovin, Hanna; Goldberg, Stuart L; Hansen, Eric; Hirsch, Jonathan; Ho, Yuk-Lam; Ip, Andrew; Izano, Monika; Jones, Jason; Justice, Amy C; Klesh, Reyna; Kuranz, Seth; Lam, Carson; Mao, Qingqing; Mataraso, Samson; Mera, Robertino; Posner, Daniel C; Rassen, Jeremy A; Siefkas, Anna; Schrag, Andrew; Tourassi, Georgia; Weckstein, Andrew; Wolf, Frank; Bhat, Amar; Winckler, Susan; Sigal, Ellen V; Allen, Jeff.
Afiliação
  • Stewart M; Friends of Cancer Research, Washington, District of Columbia, United States of America.
  • Rodriguez-Watson C; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.
  • Albayrak A; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Asubonteng J; Gilead Science, Inc. Foster City, California, United States of America.
  • Belli A; COTA, Inc., Boston, Massachusetts, United States of America.
  • Brown T; Syapse, San Francisco, California, United States of America.
  • Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Das R; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Eldridge E; Dascena, Oakland, California, United States of America.
  • Gatto N; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Gelman A; Aetion, New York, New York, United States of America.
  • Gerlovin H; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Goldberg SL; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Hansen E; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Hirsch J; COTA, Inc., Boston, Massachusetts, United States of America.
  • Ho YL; Syapse, San Francisco, California, United States of America.
  • Ip A; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Izano M; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.
  • Jones J; Syapse, San Francisco, California, United States of America.
  • Justice AC; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Klesh R; VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.
  • Kuranz S; Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America.
  • Lam C; HealthVerity, Philadelphia, Pennsylvania, United States of America.
  • Mao Q; TriNetX, Cambridge, Massachusetts, United States of America.
  • Mataraso S; Dascena, Oakland, California, United States of America.
  • Mera R; Dascena, Oakland, California, United States of America.
  • Posner DC; Dascena, Oakland, California, United States of America.
  • Rassen JA; Gilead Science, Inc. Foster City, California, United States of America.
  • Siefkas A; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Schrag A; Aetion, New York, New York, United States of America.
  • Tourassi G; Dascena, Oakland, California, United States of America.
  • Weckstein A; Syapse, San Francisco, California, United States of America.
  • Wolf F; National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.
  • Bhat A; Aetion, New York, New York, United States of America.
  • Winckler S; Syapse, San Francisco, California, United States of America.
  • Sigal EV; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.
  • Allen J; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.
PLoS One ; 16(3): e0248128, 2021.
Article em En | MEDLINE | ID: mdl-33730088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article